Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 27, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07897890). This is a study registration, not published results. Lead sponsor: Indiana University. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 12 participants (ACTUAL). Conditions: Obesity & Overweight, Breast Cancer. Interventions: BEHAVIORAL: THRIVE NOW. Primary outcome measures: Number of participants enrolled and retained , End of treatment at 8 weeks after baseline; Attendance rates (Acceptability) , Weekly attendance at each of the 8 THRIVE NOW sessions from baseline to last session; Acceptability (Program Evaluation) , End of treatment at 8 weeks after baseline. Brief summary: This study is testing an 8-week behavioral weight loss and wellness program adapted to the needs of Black/African American breast cancer survivors. The study will also examine psychological and physical factors that may be associated with weight loss outcomes.